Skip to content
10-Q/A

Quarterly Report

024 Pharma, Inc.

0001683168-17-001173

← back to feed
Filed
May 11, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 7, 2017 336.35M sh
Stockholders Equity Q1 2017 · Mar 31, 2017 $13.82K
Stockholders Equity Q1 2017 · Dec 31, 2016 $37.44K
Current Liabilities Q1 2017 · Mar 31, 2017 $9.74K
Current Assets Q1 2017 · Mar 31, 2017 $19.27K
Total Assets Q1 2017 · Mar 31, 2017 $23.56K
Net Income Q1 2017 · Mar 31, 2017 −$932
Gross Profit Q1 2017 · Mar 31, 2017 $43.32K
Cost Of Revenue Q1 2017 · Mar 31, 2017 $75.22K
Revenue Q1 2017 · Mar 31, 2017 $118.55K